OrganoTherapeutics Company

OrganoTherapeutics use mini-brains for the discovery and development of effective drug candidates targeting Parkinson’s disease.
Industry: Clinical Development
Headquarters: Esch-sur-alzette, Luxembourg, Luxembourg
Founded Date: 2019-01-01
Employees Number: 1-10
Investors Number: 2
Last Funding Date: 2020-10-21
Last Funding Type: Non-equity Assistance

Visit Website
jens.schwamborn@organo-therapeutics.com
Register and Claim Ownership